PTJ
CLPT icon

Paul Tudor Jones’s ClearPoint Neuro CLPT Stock Holding History

Paul Tudor Jones’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Buy
173,759
+16,788
+11% +$210K ﹤0.01% 1622
2026
Q1 		$1.43M Buy
+156,971
New +$1.98M ﹤0.01% 2108
2025
Q3 		– Sell
-24,317
Closed -$290K – 3420
2025
Q2 		$290K Sell
24,317
-104,381
-81% -$1.31M ﹤0.01% 2906
2025
Q1 		$1.53M Buy
+128,698
New +$2M 0.01% 1526

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Paul Tudor Jones's CLPT Position: Q2 2026 in Review

Paul Tudor Jones increased its ClearPoint Neuro (CLPT) stake by 11% in Q2 2026, buying an estimated $210K and bringing the position to 173,759 shares worth $3.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1622.

Paul Tudor Jones first reported a position in CLPT in Q1 2025 and has held it in 4 quarters since. 128 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Paul Tudor Jones held 173,759 shares of ClearPoint Neuro worth $3.1M as of Q2 2026.
  • Paul Tudor Jones bought 16,788 ClearPoint Neuro shares in Q2 2026, an estimated $210K.
  • ClearPoint Neuro made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1622 holding.
  • Paul Tudor Jones first reported a position in ClearPoint Neuro in Q1 2025 and has held it in 4 quarters since.
  • 128 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.